WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 4 fonti

Eli Lilly’s $4 Billion Vaccine Bet

In this week’s edition of InnovationRx, we look at the spreading Ebola epidemic, the Midas list health investors, Lilly’s trio of vaccine deals, and more.

Raccontata da

biopharmadive.com

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

forbes.comStai leggendo1 g fa

Eli Lilly’s $4 Billion Vaccine Bet

In this week’s edition of InnovationRx, we look at the spreading Ebola epidemic, the Midas list health investors, Lilly’s trio of vaccine deals, and more.

Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals

The deals are part of Eli Lilly’s effort to expand into infectious disease research and development.

Leggi questa versione → originale

Timeline cronologica

martedì 26 maggio 2026·biopharmadive.com
Lilly dives into vaccine research with 3 biotech buyouts
Worth close to $4 billion combined, the acquisitions of Curevo, LimmaTech and Vaccine Co. signal plans by Lilly to build an infectious disease portfolio.
martedì 26 maggio 2026·statnews.com
Eli Lilly to buy three small vaccine developers
Eli Lilly is acquiring three small vaccine developers, expanding its work in infectious diseases and giving the field a boost.

statnews.com1 g fa

Eli Lilly to buy three small vaccine developers

Eli Lilly is acquiring three small vaccine developers, expanding its work in infectious diseases and giving the field a boost.

Leggi questa versione → originale

biopharmadive.com2 g fa

Lilly dives into vaccine research with 3 biotech buyouts

Worth close to $4 billion combined, the acquisitions of Curevo, LimmaTech and Vaccine Co. signal plans by Lilly to build an infectious disease portfolio.

Leggi questa versione → originale

martedì 26 maggio 2026·

cnbc.com

Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals

The deals are part of Eli Lilly’s effort to expand into infectious disease research and development.

mercoledì 27 maggio 2026·

forbes.com

Eli Lilly’s $4 Billion Vaccine Bet

In this week’s edition of InnovationRx, we look at the spreading Ebola epidemic, the Midas list health investors, Lilly’s trio of vaccine deals, and more.

mercoledì 27 maggio 2026·

forbes.com

The Ebola Epidemic Is Spreading

In this week’s edition of InnovationRx, we look at the spreading Ebola epidemic, the Midas list health investors, Lilly’s trio of vaccine deals, and more.